SANTA CLARA, Calif., March 13, 2023 – IP Infusion, a leading provider of open network software solutions for Total Network Disaggregation, announced today that the company closed out 2022 with an almost 90 percent year-over-year (YoY) USD sales increase. The continuing positive momentum is attributed to growing global demand for IP Infusion's OcNOS® networking operating system, which experienced two times YoY sales growth from both new and repeat customers. Nearly 90 new customer logos were added to IP Infusion's sales roster as well as 28 PartnerInfusion partners coming on board.
This significant business growth, intensifying in YoY trending throughout 2022, demonstrates the strong appeal of IP Infusion's OcNOS solutions. These solutions propel innovation, services and higher revenue potential while reducing operators' Total Cost of Ownership. The high rate of return customers also underscores IP Infusion's successful deployments, field-tested quality and acclaimed customer service.
IP Infusion's PartnerInfusion program, a highly curated ecosystem of the industry's top partners fueling open network innovation, helps its customers enact game-changing network disaggregation. Broadband aggregation installations, including solutions with Netomnia and WOW! also factored in growth for next-gen aggregation market successes. Collaborations with top infrastructure leaders, including: Aircom International, Antriksh Technosys, ASBIS, AVISTA, Broadcom, dacoso GmbH, Distri X, DongFong Tech, Edgecore, EPS Global, GIOFAT, Fujitsu Network Communications, HFCL Limited, Integra Gulf Company, Intracom Africa, IP ArchiTechs, Jabil, KGPCo, N-able, Netjer Networks, Marvell Technologies, RocNet, SoftNet Solutions, Softrim, Syncworks, Tradex, UfiSpace, and UNIS Telecom, help ensure diversity and choice for customers.
IP Infusion's new customers in 2022 include leading network operators from all over the globe: Afribone, Asia-Pacific Telecommunity (APT), ASOM-Net, Ceragon Networks, Extreme Labs, JSC Kazakhtelecom, Lintasarta, Mobicom Corporation, Mundo Pacífico, OpenX, SKY Brasil, uGrid Network Inc., Virtual Technologies and Solutions (VTS) and WOW!.
Other milestones for 2022 included accolades from the Telecom Infra Project (TIP), an international community of companies and organizations driving development and deployment of open, disaggregated, and standards-based technology solutions to advance global connectivity. TIP recognized IP Infusion's OcNOS with its Validated Solution Gold Badge, the first of its kind assigned in 2022. IP Infusion's OcNOS software was highly recognized for satisfying the stringent requirements set by the TIP Open Optical Packet Transport Project (OOPT) group for the Disaggregated Cell Site Gateway (DCSG).
IP Infusion also successfully demonstrated the maturity and stability of its OcNOS-based DCSG solution addressing Fronthaul use cases at the O-RAN Global PlugFest Spring 2022. The O-RAN Alliance is a preeminent open technical organization comprising more than 350 companies and institutions transforming worldwide Radio Access Networks (RAN) to be intelligent, virtualized and fully interoperable. In addition, GigaOm named IP Infusion a Leader, Outperformer and Platform player for all three 2022 Network Operating System (NOS) Radar Reports.
"IP Infusion's ability for sustained growth speaks to our success in delivering powerful open networking solutions that provide flexibility in evolving market conditions and ongoing supply chain challenges," said Atsushi Ogata, President and CEO of IP Infusion. "It's also rewarding to have new customers embracing our disaggregated solutions to upgrade their networks, and gratifying that so many satisfied customers continue to return to further expand and innovate with OcNOS."
Acerca de IP Infusion
IP Infusion is a leading provider of open network software and solutions for carriers, service providers and data center operators with over 500 customers and thousands of deployments. Our solutions enable network operators to disaggregate their networks to accelerate innovation, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier grade robustness.
IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.
IP Infusion and OcNOS are trademarks or registered trademarks of IP Infusion. ACCESS is a registered trademark or trademark of ACCESS CO., LTD. in the United States, Japan and/or other countries. Northforge Innovations is a registered trademark of Northforge Innovations, Inc. All other trademarks, service marks, registered trademarks, or registered service marks mentioned are the property of their respective owners.
-end-
Contacto de prensa
Katherine Verducci
1903 PR
kverducci@1903pr.com
408.429.5779
Acerca de IP Infusion
IP Infusion es un proveedor líder de software de open networking y desarrolla OcNOS, un sistema operativo de red de nivel operador para proveedores de servicios, centros de datos y redes AI fabric. Con 26+ años de experiencia en redes y 600+ operadores en todo el mundo, IP Infusion habilita una infraestructura de red abierta, multiproveedor, rentable y flexible sobre hardware abierto validado de socios como Edgecore Networks, UfiSpace y Celestica. IP Infusion es una filial de propiedad total de ACCESS CO., LTD. (Tokyo Stock Exchange: 4813).
Contacto de prensa
For press inquiries, analyst briefings, or media materials, please contacte con nuestro equipo or email pr@ipinfusion.com.
Declaraciones prospectivas
Este comunicado puede contener declaraciones prospectivas sobre los productos, la tecnología y los planes de IP Infusion. Las declaraciones prospectivas se basan en la información disponible en la fecha de publicación e implican riesgos e incertidumbres. Los resultados reales pueden diferir. Los planes de producto, las funcionalidades, el calendario de versiones y la disponibilidad están sujetos a cambios sin previo aviso y no constituyen un compromiso, una promesa ni una obligación legal. IP Infusion no asume ninguna obligación de actualizar las declaraciones prospectivas.